Clinical Trial Update: This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

View source ↗

Summary

This completed study from Menoufia University investigates genetic polymorphisms affecting doxorubicin pharmacokinetics and toxicity in Egyptian women with brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Menoufia University | Conditions: Breast Cancer | Status: COMPLETED